Table 1. Aggregate clinical data for VL patients.
| N | 84 |
| Age (years) | 29.45±17.6 |
| Sex (M/F) | 51/33 |
| Duration of illness (days) | 37.31±35.29 (30) |
| WBC counts, pre treatment | 3332±1183 (3100) |
| WBC counts, post treatmenta | 6795±2887 (6300) |
| Spleen Size (cm), pre treatment | 4.43±2.82 (4) |
| Spleen Size (cm), post treatmenta | 0.81±1.42 (0) |
| Splenic Scoreb | 2.37±1.11c |
Median values are given within brackets.
a
Post treatment values are from day 15 or day 30 post treatment.
b
Scoring of parasite load is on a logarithmic scale from 1 to 6, were 0 is no parasites per 1000 microscopic fields (1000×), 1 is 1–10 parasites per 1000 fields, and 6 is >100 parasites per field. ND = not done; NA = not applicable.
c
Splenic scores presented are only based on patients used to assess the ex-vivo effect of IFNγ blockade.